SFI
ATOS icon

Susquehanna Fundamental Investments’s Atossa Therapeutics ATOS Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,319
Closed -$29K – 1201
2022
Q3 		$29K Buy
+2,319
New +$33.7K ﹤0.01% 1389
2022
Q1 		$140K Sell
7,460
-1,201
-14% -$24.4K ﹤0.01% 1419
2021
Q4 		$208K Buy
8,661
+2,331
+37% +$85.3K 0.01% 1237
2021
Q3 		$310K Buy
+6,330
New +$368K 0.01% 1396
2020
Q4 		– Sell
-1,127
Closed -$41K – 1493
2020
Q3 		$41K Buy
+1,127
New +$54.1K ﹤0.01% 1326

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return